What were Praluent (alirocumab) sales in 2024?
The provided information does not include Praluent’s 2024 sales figures (such as total revenue, quarterly sales, or geography-specific performance).
Where to find official Praluent 2024 sales numbers
If you’re trying to locate the exact 2024 sales figure, the most reliable places are typically:
- The company’s quarterly and full-year earnings releases and investor presentations for the year that includes 2024
- SEC filings (for US-listed companies) that include product revenue breakdowns
Which “sales” do people usually mean (and what to check)
Searchers often mean different metrics, so the source matters:
- US sales vs. global sales
- Total revenue vs. net sales (after rebates/returns)
- Gross sales reported by the manufacturer vs. adjusted metrics
If you tell me which company you mean (Regeneron and/or Sanofi, or a specific ticker) and whether you want US or global sales, I can narrow the query format to the right reporting source.
Do you mean prescription volume instead of revenue?
Some users ask “sales” but actually want utilization trends (e.g., prescriptions or treated patients). Those usually come from different data providers than financial reports.
Quick clarification
Do you want Praluent 2024 sales for:
1) global net sales, or
2) US net sales, and which year definition (calendar year 2024 vs. fiscal 2024)?